REGNREGENERON PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of REGENERON PHARMACEUTICALS, INC. against its industry peers — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REGN본 종목 | — | 19.1x#1 | — | — | 1.0%#4 | 2.1%#4 | 24.9%#3 | 14.2%#4 | 9.4%#4 | — | 35.0%#2 | — |
| VRTX | $130.4B#3 | 30.0x#3 | 6.4x#1 | 10.9x#3 | 8.9%#2 | 838.1%#2 | 34.8%#1 | 19.5%#3 | 25.0%#2 | — | 31.0%#4 | — |
| AMGN | $203.1B#1 | 23.3x#2 | 17.4x#3 | 5.5x#1 | 10.0%#1 | 88.5%#3 | 24.7%#4 | 66.0%#2 | 15.1%#3 | — | 40.3%#1 | 2.5%#1 |
| GILD | $181.4B#2 | — | 15.3x#2 | 6.2x#2 | 2.4%#3 | 1672.9%#1 | 34.0%#2 | 71.9%#1 | 26.7%#1 | — | 32.9%#3 | 2.2%#2 |
Peer set: Tickwind's hand-curated industry grouping. Values from SEC filings + delayed prices; ranks are sorted positions within this group only — descriptive, not a rating or advice. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice